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ABSTRACT
Arboviruses have been emerging in different parts of the world due to genetic changes in the 
virus, alteration of the host and vector population dynamics, or because of anthropogenic 
environmental factors. These viruses’ capacity for adaptation is notable, as well as the likelihood of 
their emergence and establishment in new geographic areas. In Brazilian epidemiologic scenario, 
the most common arboviruses are DENV, CHIKV, and ZIKV, although others may spread in the 
country. Little is yet known of the impact of viral co-circulation, which would theoretically result 
in more intense viremia or other immunological alterations that could trigger autoimmune 
diseases, such as Guillain-Barré syndrome. The impact on morbidity and mortality intensifies as 
extensive epidemics lead to a high number of affected individuals, severe cases, and implications 
for health services, mainly due to the absence of treatment, vaccines, and effective prevention 
and control measures. 
DESCRIPTORS: Dengue. Zika Virus Infection. Chikungunya Fever. Arbovirus Infections, 
epidemiology. Communicable Diseases, Emerging.
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EMERGENCE OF ARBOVIRUSES
Arboviruses (ARthropod-Borne VIRUS) have caused much concern in public health 
worldwide. This set is composed of hundreds of viruses that share the characteristic of 
transmission by arthropods – mostly hematophagous mosquitoes –, although they are not 
necessarily phylogenetically related26. The most important viruses for human health are 
those transmitted by culicidae, mainly of the Culex and Aedes genera, although a number of 
arboviruses can be transmitted by other arthropods, such as sand flies and ticks26.
Most arboviruses belong to the Alphavirus (Togaviridae family) and Flavivirus (Flaviviridae 
family) genera; other members important to human health are from the Bunyaviridae, 
Reoviridae, and Rhabdoviridae families26.
This group of RNA viruses represents major genetic plasticity and high mutation frequency, 
which allows them to adapt to vertebrate and invertebrate hosts3. Arboviruses, in general, 
circulate among wild animals, with some specificity for hosts, maintaining enzootic cycles 
in few vertebrate and invertebrate species. Humans and pets are generally accidental hosts14. 
This occurs in the circulation of yellow fever, which is found in Brazil in wild outbreaks, 
without cyclical characteristics, associated with epizooties. We noted the geographic 
expansion of the circulation of the yellow fever virus from 2000 to 200924 and reemergence 
in the Midwest and Southeast, since 2014. Another example of enzootic cycles involves the 
Mayaro virus (MAYV), mainly transmitted by wild mosquitoes of the Haemagogus genus, for 
which the vertebrate hosts are mammal. In humans, it causes fever, headache, exanthema, 
and arthralgia; however, cases of sustained transmission were not observed. There is evidence 
of the adaptive capacity of MAYV to alternative cycles involving birds and humans14.
The West Nile Virus (WNV) can cause epidemics even in urban areas, as occurs in the United 
States. It is transmitted by mosquitoes of the Culex genus, and its main host is birds26. Some 
viruses lose the demand for enzootic amplification and produce urban epidemics, with 
humans as exclusive vertebrate amplifiers. Such is the case of the Dengue virus (DENV), 
Chikunguya (CHIKV), and, lately, Zika (ZIKV)26.
The emergent lineage of yellow fever virus in the South region in 200824 is worth noting, 
with the participation of Haemagogus leucocelaenus as the main vector and Aedes serratus 
for transmission2. The presence of this last vector in woods near urban areas also in the 
Southeast of Brazil signals potential for the occurrence of peri-urban cycles of yellow fever2. 
In the current Brazilian epidemiologic scenario, the most common arboviruses are DENV, 
CHIKV, and ZIKV, as well as the yellow fever virus currently expanding and other arboviruses 
with potential for dissemination in the country14. 
The dramatic dissemination of dengue in the Americas in the last decades has been well 
documented, with over two million notified cases in 2015 (until December 8th), adding up to 
1.5 million in Brazil, with 811 deaths and an incidence rate of 763 per 100 thousand inhabitantsa.
Another forthcoming arbovirus is CHIKV, which began pandemic expansion in 2004. 
A mutation in an African lineage of CHIKV allowed it to adapt well to the A. albopictus 
vector through the alteration of a protein in the viral envelope E1 (E1-A226V), which was 
followed by other adaptive steps. This increased the ability of CHIKV to infect and spread 
in that vector, an abundant species in the Indian Ocean islands and in other regions of 
Asia3. The adaptation favored the expansion of the virus in urban and peri-urban areas on 
that continent and increased the risk of epidemics in other tropical, subtropical, and even 
temperate regions, such as Europe. Essa adaptação favoreceu a expansão da virose em áreas 
urbanas e periurbanas naquele continente e aumentou o risco de epidemias em outras 
regiões tropicais, subtropicais e mesmo temperadas, como Europa23. The autochthonous 
transmission of an Asian lineage of CHIKV without these mutations was registered in the 
Caribbean since the end of 201313. In Brazil, autochthonous transmission was detected in 
September 2014 in Amapá, spreading to other Brazilian states1,21.
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The ZIKV, identified for the first time in Uganda in 1947, had its first documented outbreak only 
in 2007 in Micronesia. Since then, the transmission area has spread to islands in the Pacific 
Ocean, especially during a great epidemic in Polynesia in October 20135,18. Since April 2015, 
autochthonous transmission of ZIKV was confirmed in Bahia1 and then in Rio Grande do 
Norte, Pernambuco, Rio de Janeiro, São Paulo, and other states, with patients presenting 
clinical conditions of exanthematous fevera. In the following months, the transmission of 
ZIKV was confirmed in various countries of the Americas – Colombia in October; Guatemala, 
El Salvador and Surinam in November; Honduras, Panama, Venezuela, Mexico, and Paraguay in 
December – where transmission was likely associated with the vector A. aegypti. Genetic changes 
among viral lineages allowed the virus to better adapt to the vector and to human transmission8.
The co-circulation of infection by DENV, CHIKV, and ZIKV in Brazil makes clinical management 
difficult due to similarities; it has implications in the transmission in older people, pregnant 
women, and young children, and presents a still limited laboratorial rear-guard. Little is yet 
known of the impact of the co-circulation of this virus. As in the case of reinfection by different 
serotypes of DENV, the interaction of arboviruses (DENV serotypes 1-4, CHIKV, and ZIKV) 
could theoretically result in more intense viremia or other immunological alterations which, 
in turn, would trigger autoimmune diseases such as Guillain-Barré syndrome4,5,12,18. 
Other arboviruses of the Flaviviridae family pose a real threat of epidemic circulation in 
Brazil, including WNV, the most common arbovirus in the world. Since its introduction in 
1999, this virus has rapidly expanded throughout the Americas. In the first decade of the 
21st century, a phenotypical variation increased the efficiency of transmission in Culex 
ssp. mosquitoes6. In Brazil, serological indications of viral circulation were detected in 
various vertebrate species in the Pantanal of Mato Grosso and in the Northeast, warning of 
the possibility of human cases occurring in the region17,20. In 2014, the first human case of 
neuro-invasive disease by WNV in Brazil was serologically confirmed in a resident of the rural 
area of Piauí state25. Viruses such as MAYV, of the Alphavirus genus, and the Oropouche virus 
(OROV), of the Orthobunyavirus genus from the Bunyaviridae family, have been frequently 
identified in the Amazonian region in patients with nonspecific feverish conditions or with 
neurological damage7,15,16. Other arboviruses have been isolated in humans in Brazil, such as 
Saint Louis encephalitis, in a dengue-suspect case in the state of São Paulo19, Ilhéus, Rocio14, 
and Bussuquara14 (Flavivirus genus), suggesting possible emergence. 
CLINICAL PRESENTATION OF THE ARBOVIRUSES 
The clinical manifestations of infection by arbovirus can vary from light feverish 
undifferentiated disease to neurological, articular, and hemorrhagic feverish syndromes. 
Frequently, severe cases are only identified after viral circulation in extensive epidemics, many 
times reflecting the unpredictable impact on morbidity and mortality, while the occurrence, 
until now, has been restricted to isolated cases or small outbreaks.
Deaths by CHIKV in epidemics were not known until the epidemic of Reunion Island in the 
Indian Ocean, where severe neurological cases were registered (encephalitis with deaths 
and aftereffects) and perinatal transmission with encephalitis and retardation of neuro-
psychomotor development in children9. Similarly, infection by ZIKV was considered an 
exanthematous benign disease with light, self-limited symptoms, since few cases were 
known. The diagnosis was changed, however, during the epidemic of October 2013 to 
March 2014 in French Polynesia, with 29 thousand estimated cases and the notification of 
neurological conditions (encephalitis, myelitis, and peripheral paralysis) associated with 
ZIKV12,18. In addition, occurrences of Guillain-Barré syndrome multiplied by eight times in 
that location during the time of the epidemic, suggesting that the virus contributed to the 
etiology of the cases12,18. After the emergence of ZIKV in Brazil and the rest of the Americas, 
the infection was associated with Guillain-Barré syndrome, fatal encephalitis in adults, deaths 
of fetuses, microcephaly, and other malformations of fetuses, (congenital Zika syndrome).
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Dengue, after its re-emergence in the context of major epidemics, hyperendimicity and 
co-circulation of various serotypes, has also been associated with the rise in severe cases 
throughout the world. Immunity obtained in previous infections leads to the amplification 
mediated by ADE (antibody dependent enhancement) antibodies, with high viremia and 
release of inflammatory markers in reinfections by different serotypes, particularly in the 
second infections11.
Until the emergence of WNV in Romania, with a fatality rate of 10%, the neurological forms 
were considered rare22. Since 1999, in the United States, the rapid dispersion of the virus 
and association with greater epidemics of encephalitis in the country were notable, with 
heavy impact on morbidity and mortality. Outbreaks in Europe and the Americas still occur, 
suggesting the geographic expansion of the disease10.
The impact of arboviruses on morbidity and mortality intensifies as the extended epidemics 
assume a great number of affected individuals, with implications on the health services, 
mainly in light of the absence of treatment, vaccines, and other effective methods of 
prevention and control.
On the other hand, environmental pressure has led to the selection of viral lineages that 
cause more intense viremia and, consequently, higher pathogeny of the disease, as in 
the case of CHIKV and WNV. These viruses are highly adaptable, and can easily emerge 
and establish themselves in new geographic areas, suggesting that new and old viruses 
could potentially reappear. A few arboviruses with higher potential of circulation in 
Brazil are Saint Louis and West Nile (Flaviviridae family), Oropouche (Bunyaviridae 
family), Venezuelan encephalitis virus, and Mayaro (Togaviridae family), all of which can 
be associated with severe cases, especially if extensive epidemics occur. All of them have 
proven to be capable of transmission via potentially urban arthropods of the Diptera 
order, such as Culicoides paraensis, Aedes ssp., and Culex ssp., which are widely occurring 
in the country14.
PERSPECTIVES
Arboviruses are a growing public health problem worldwide, mainly due to the potential 
of dispersion, adaptability to new environments and hosts (vertebrate and invertebrate), 
possibility of causing extensive epidemics, universal susceptibility, and occurrence of 
high numbers of severe cases, with neurological, articular, and hemorrhagic damage. 
The introduction of any arbovirus in an indemnified environment or one with the presence 
of the vector should never be neglected.
The fight against emerging arboviruses requires wide-ranging policies and interventions 
involving various sectors of society, not only the health sector.
The definitive establishment of Aedes in the Americas was associated with climate change, 
deforestation, disorganized urbanization, growth of cities, absence of water and basic 
sanitation, and population displacement. These factors define the paths of the diseases, 
influenced by the pressure of the viral mutation and genetic adaptations of the viruses to 
hosts, vectors, and new environments. Despite difficulties regarding socioeconomic and 
environmental factors, the health sector has responsibilities, such as investments in the 
prevention, diagnosis, and treatment of infections; for example, in the particularly critical 
case of pregnant women affected by ZIKV.
The development of vaccines has been a challenge for many study groups in Brazil and 
worldwide, considering its proven viability for various Flaviviruses. 
Investments in the qualification of the actions of epidemiologic, virologic, vectorial, and 
epizootic surveillance are urgent in the country, especially during times of risks important 
to public health. International collaboration is essential for the early identification of the 
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entrance of new pathogens in indemnified regions; however, integrated policies and actions 
are particularly strategic in a country the size of Brazil.
Perplexity regarding the spread of ZIKV and CHIKV and their impact in Brazil were 
sufficient to establish a state of public health emergency by the Ministry of Health and 
World Health Organization, almost two years after the entrance of the virus in the country. 
This condition implied an intense mobilization of resources and articulations among 
states and municipals to combat viral circulation, which took on huge proportions. Thus, 
the epidemiologic investigation and suspicion of other arboviruses must be part of the 
epidemiologic surveillance routines and concerns of national public health to predict new 
epidemiologic emergences. On the other hand, the efforts are essential to the development 
and improvement of agile, sensitive diagnostic exams with little cross-reactions with other 
arboviruses – specific immunobiologicals and synthesis of antiviral medication, mainly due 
to the infection of pregnant women by ZIKV. Joint actions in research and the fight against 
the vectors could affect the expansion of emerging viruses, such as infection by CHIKV and 
ZIKV, the greatest concerns in the country at the moment. 
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